GDUFA Research Outcomes
BE Methods & Analyses
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to bioequivalence methods and analyses for generic drug products.
-
Use of Modeling and Simulation to Support New BE Approaches
Zhao, Liang
-
Introduction & Overview: Current Regulatory Horizon of Narrow Therapeutic Index Drugs & ICH Guideline Development for Bioequivalence Assessment
Zhang, Lei
-
Opening Remarks – Global Bioequivalence Harmonization: Enhancing Access to Affordable Medicines
Zhang, Lei
-
Regulatory Science to Support Global Harmonization for Establishing BE for Generic Oral Products
Zhang, Lei
-
ICH M13 Guideline Series
Zhang, Lei
-
Essential Elements of BCS III-Based Biowaiver Request
Zhang, Yi
-
Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA
Tampal, Nilufer
-
Regulatory Research on the Effect of Excipients on Drug Absorption
Zhang, Lei
-
Biopharmaceutics Classification System Class 3 Waiver
Zhang, Yi
-
Intestinal Influx Transporters: A Missing Piece in the Puzzle?
Zhang, Lei